Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Frontiers in Public Health|May 19, 2023
Recombinant mycobacterium tuberculosis fusion protein for diagnosis of mycobacterium tuberculosis infection: a short-term economic evaluationZheng Liu, Sha Diao, Linan Zeng, et al.
Frontiers in Pharmacology|June 1, 2023
Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infectionSha Diao, Zheng Liu, Dan Liu, et al.
Acta Pharmaceutica Sinica. B|January 26, 2026
Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelineChen Shi, Hong Zhou, Liangru Zhu, et al.
Journal of Zhejiang University. Science. B|September 23, 2025
A practice guideline for therapeutic drug monitoring of mycophenolic acid for solid organ transplantsShuang Liu, Hongsheng Chen, Zaiwei Song, et al.
Journal of Evidence-Based Medicine|December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)Zhiling Zhang, Pengxiang Zhou, Na He, et al.
British Journal of Clinical Pharmacology|November 3, 2021
Medication therapy of high-dose methotrexate: An evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological SocietyZaiwei Song, Yang Hu, Shuang Liu, et al.
Journal of Clinical Medicine|February 25, 2023
Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022)Chen Shi, Zhaoming Ye, Zengwu Shao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological SocietyNa He, Shan Su, Zhikang Ye, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Evidence-based expert consensus on clinical management of safety of Bruton's tyrosine kinase inhibitors (2024)Zaiwei Song, Dan Jiang, Lingling Yu, et al.
Pageof 7